Loading...
PharmAust Limited
PAA.AX•ASX
Healthcare
Biotechnology
A$0.23
A$0.02(6.98%)
PharmAust Limited (PAA.AX) Financial Performance & Income Statement Overview
Review PharmAust Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-100.00%
↓ 100.00%
Operating Income Growth
-83.81%
↓ 83.81%
Net Income Growth
-45.41%
↓ 45.41%
Operating Cash Flow Growth
-230.43%
↓ 230.43%
Operating Margin
-776.66%
↓ 776.66%
Gross Margin
99.81%
↑ 99.81%
Net Profit Margin
-896.47%
↓ 896.47%
ROE
-86.89%
↓ 86.89%
ROIC
-65.10%
↓ 65.10%
PharmAust Limited (PAA.AX) Income Statement & Financial Overview
Review PharmAust Limited's (PAA.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $857347.00 | $908813.00 | $1.92M |
| Cost of Revenue | $1641.00 | $0.00 | $2.05M | $1.71M |
| Gross Profit | -$1641.00 | $857347.00 | -$1.14M | $208186.00 |
| Gross Profit Ratio | $0.00 | $1.00 | -$1.25 | $0.11 |
| R&D Expenses | $2.52M | $1.32M | $602149.00 | $429581.00 |
| SG&A Expenses | $1.67M | $1.14M | $908160.00 | $753199.00 |
| Operating Expenses | $4.19M | $2.46M | $1.51M | $1.18M |
| Total Costs & Expenses | $4.19M | $2.46M | $3.56M | $2.89M |
| Interest Income | $20513.00 | $3955.00 | $78785.00 | $2240.00 |
| Interest Expense | $0.00 | $0.00 | $39848.00 | $42014.00 |
| Depreciation & Amortization | $1641.00 | $86234.00 | $163057.00 | $163492.00 |
| EBITDA | -$7.29M | -$2.16M | -$5.99M | -$469782.00 |
| EBITDA Ratio | $0.00 | -$1.77 | -$2.73 | -$0.42 |
| Operating Income | -$4.19M | -$2.46M | -$2.65M | -$974590.00 |
| Operating Income Ratio | $0.00 | -$2.87 | -$2.91 | -$0.51 |
| Other Income/Expenses (Net) | -$3.10M | $307870.00 | -$3.54M | $299297.00 |
| Income Before Tax | -$7.30M | -$2.16M | -$6.19M | -$675293.00 |
| Income Before Tax Ratio | $0.00 | -$2.52 | -$6.81 | -$0.35 |
| Income Tax Expense | -$1.00 | -$553435.00 | $3.00 | -$654109.00 |
| Net Income | -$7.30M | -$389244.00 | -$6.19M | -$21184.00 |
| Net Income Ratio | $0.00 | -$0.45 | -$6.81 | -$0.01 |
| EPS | -$0.02 | -$0.001 | -$0.02 | -$0.00 |
| Diluted EPS | -$0.02 | -$0.001 | -$0.02 | -$0.00 |
| Weighted Avg Shares Outstanding | $445.02M | $353.86M | $321.02M | $316.91M |
| Weighted Avg Shares Outstanding (Diluted) | $445.02M | $353.86M | $321.02M | $316.91M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan